Sponsor or institution

Clinical trials and research at Ranok Therapuetics Co. Ltd.

As of November 12, 2026, Find a Trial lists 3 clinical trials run by Ranok Therapuetics Co. Ltd. that are recruiting, at sites in 2 countries (most in China (3), United States (1)). By phase: Phase 1/2 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
RNK08954 treatment for metastatic pancreatic ductal adenocarcinoma with KRAS G12D mutation Phase 2 Nanjing and 1 other locations Recruiting Dec 24, 2025
Evaluating RNK08954 for Advanced Solid Tumors with KRAS G12D Mutation Phase 1/2 Nanning, Guangxi and 5 other locations Recruiting Oct 31, 2024
Evaluating RNK05047 for advanced solid tumors and DLBCL Phase 1/2 Atlanta, Georgia and 4 other locations Recruiting Aug 4, 2022

All recruiting trials (3)

Quick answers

How many clinical trials run by Ranok Therapuetics Co. Ltd. are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in China (3 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.